The article research the simulation-based mathematical modeling of bioheat switch below the Dirichlet boundary situation. We used advanced non-linear dual-phase-lag bioheat switch (DPLBHT) for analyzing the temperature distribution in pores and skin tissues throughout hyperthermia remedy of contaminated cells. The perfusion time period, metabolic warmth supply, and exterior warmth supply had been the three elements of the volumetric warmth supply that had been used within the mannequin.
The non-linear DPLBHT mannequin predicted a extra correct temperature inside pores and skin tissues. The finite ingredient Runge-Kutta (4,5) (FERK (4,5)) technique, which was based mostly on two methods, finite distinction and Runge-Kutta (4,5), was utilized for calculating the outcome within the case of our typical non-linear drawback. The paper research and presents the non-dimensional unit. Thermal harm of regular tissue was noticed close to zero throughout hyperthermia remedy.
The results of the non-dimensional time, non-dimensional area coordinate, location parameter, regional parameter, leisure and thermalization time, metabolic warmth supply, related metabolic warmth supply parameter, perfusion price, related perfusion warmth supply parameter, and exterior warmth supply coefficient on the dimensionless temperature profile had been studied intimately through the hyperthermia remedy course of.
Design and analysis of ciprofloxacin loaded collagen chitosan oxygenating scaffold for pores and skin tissue engineering
Hypoxia and sepsis are the important thing considerations in direction of trendy regenerative drugs. Oxygen producing biomaterials having antibacterial property intention to reply these considerations. Hypoxia and Sepsis promote reactive oxygen species (ROS) era on the implant website that delays wound therapeutic. Due to this fact, scaffolds with antibacterial property and oxygen-producing capacities have proven potential to advertise wound therapeutic. Within the current research oxygen releasing, ciprofloxacin loaded collagen chitosan scaffold was fabricated for sustained oxygen supply.
Calcium peroxide (CPO) acted as a chemical oxygen supply. Oxygen launch sample exhibited a sustained launch of oxygen with uniform deposition of CPO on the scaffold. The drug launch research confirmed a chronic, steady, and sustained launch of ciprofloxacin. Cell tradition research depicted that scaffold has appropriate cell attachment and migration properties for fibroblasts. In vivo research carried out within the pores and skin flip mannequin visually confirmed higher wound therapeutic and fewer necrosis. Histological research confirmed the upkeep of tissue structure and the deposition of collagen. Total, our outcomes demonstrated that the proposed CPO coated ciprofloxacin loaded collagen- chitosan scaffold could possibly be a promising candidate for pores and skin tissue engineering.
Transmission Coefficient of Energy Density Into Pores and skin Tissue Between 6 And 300 Ghz
The most recent electromagnetic security pointers outline transmitted or epithelial energy density as the essential restriction above 6 GHz. On this notice, we derive an approximation for a conservative transmission coefficient for quasi airplane wave incidence as a perform of the frequency for the conventional element of the Poynting vector with respect to the analysis airplane or tissue floor |Sz inc| and for its modulus ||Sinc||. The utmost transmission coefficient for the conventional element of the Poynting vector ${\boldsymbol{T}}_{\mathbf{z}}^{\mathbf{max}}$ is 1 unbiased of tissue composition and frequency.
Approximations of ${\boldsymbol{T}}_{\mathbf}^{\mathbf{max}}$ normalized to ||Sinc|| for skinny and thick stratum corneum are supplied permitting larger exposures. These approximations permit to conservatively exhibit compliance with fundamental restrictions when quasi plane-wave circumstances are domestically glad and enhancement results of standing waves between supply and physique might be uncared for. The reported outcomes are essential to regulators and standardization our bodies relating to revisions of compliance necessities and security pointers.
Mapping 2D- and 3D-distributions of steel/steel oxide nanoparticles inside cleared human ex vivo pores and skin tissues
An growing variety of business skincare merchandise are being manufactured with engineered nanomaterials (ENMs), prompting a necessity to completely perceive how ENMs work together with the dermal barrier as a serious biodistribution entry route. Though animal research present that sure nanomaterials can cross the pores and skin barrier, physiological variations between human and animal pores and skin, reminiscent of the shortage of sweat glands, restrict the translational validity of those outcomes.
Present optical microscopy strategies have restricted capabilities to visualise ENMs inside human pores and skin tissues as a result of excessive quantity of background gentle scattering brought on by the dense, ubiquitous extracellular matrix (ECM) of the pores and skin. Right here, we hypothesized that natural solvent-based tissue clearing (“immunolabeling-enabled three-dimensional imaging of solvent-cleared organs”, or “iDISCO”) would cut back background gentle scattering from the extracellular matrix of the pores and skin to sufficiently enhance imaging distinction for each 2D mapping of unlabeled steel oxide ENMs and 3D mapping of fluorescent nanoparticles.
We efficiently mapped the 2D distribution of label-free TiO2 and ZnO nanoparticles in cleared pores and skin sections utilizing correlated indicators from darkfield, brightfield, and confocal microscopy, in addition to micro-spectroscopy. Particularly, hyperspectral microscopy and Raman spectroscopy confirmed the identification of label-free ENMs which we mapped inside human pores and skin sections.
cDNA - Human Diabetic Diseased Tissue: Kidney |
C1236142Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Spleen |
C1236246Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Stomach |
C1236248Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Pancreas |
C1236188Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Esophagus |
C1236106Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Whole Eye |
C1236108Dia-10 |
Biochain |
10 reactions |
EUR 432 |
cDNA - Human Diabetic Diseased Tissue: Lymph Node |
C1236161Dia-10 |
Biochain |
10 reactions |
EUR 432 |
cDNA - Human Diabetic Diseased Tissue: Bone Marrow |
C1236024Dia-10 |
Biochain |
10 reactions |
EUR 462 |
cDNA - Human Diabetic Diseased Tissue: Skeletal Muscle |
C1236171Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Visceral Adipose |
C1236003VisDia-10 |
Biochain |
10 reactions |
EUR 462 |
cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
C1236003SubDia-10 |
Biochain |
10 reactions |
EUR 462 |
Genomic DNA - Human Diabetic Diseased Tissue: Skin, from a single donor |
D1236218Dia |
Biochain |
50 ug |
EUR 562 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
C1236227Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
C1236230Dia |
Biochain |
40 reactions |
EUR 802 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
C1236101Dia |
Biochain |
40 reactions |
EUR 802 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Eye |
T1236108Dia |
Biochain |
5 slides |
EUR 728 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Lung |
T1236152Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Brain |
T1236035Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Colon |
T1236090Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Heart |
T1236122Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Liver |
T1236149Dia |
Biochain |
5 slides |
EUR 523 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung |
T2236152Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Kidney |
T1236142Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Spleen |
T1236246Dia |
Biochain |
5 slides |
EUR 523 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Colon |
T2236090Dia |
Biochain |
5 slides |
EUR 262 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Liver |
T2236149Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Adrenal |
T1236004Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Stomach |
T1236248Dia |
Biochain |
5 slides |
EUR 523 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
T1236188Dia |
Biochain |
5 slides |
EUR 523 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Stomach |
T2236248Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
T1236106Dia |
Biochain |
5 slides |
EUR 523 |
Total Protein - Human Diabetic Diseased Tissue: Lung |
P1236152Dia |
Biochain |
1 mg |
EUR 542 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
T2236106Dia |
Biochain |
5 slides |
EUR 262 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
T2236188Dia |
Biochain |
5 slides |
EUR 262 |
Total Protein - Human Diabetic Diseased Tissue: Brain |
P1236035Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Colon |
P1236090Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Heart |
P1236122Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Liver |
P1236149Dia |
Biochain |
1 mg |
EUR 542 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Parathyroid |
T2236189Dia |
Biochain |
5 slides |
EUR 692 |
Total Protein - Human Diabetic Diseased Tissue: Kidney |
P1236142Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Spleen |
P1236246Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Adrenal |
P1236004Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Stomach |
P1236248Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Pancreas |
P1236188Dia |
Biochain |
1 mg |
EUR 542 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
T1236024Dia |
Biochain |
5 slides |
EUR 728 |
Total Protein - Human Diabetic Diseased Tissue: Esophagus |
P1236106Dia |
Biochain |
1 mg |
EUR 542 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
T2236024Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Visceral Adipose |
T1236003VisDia |
Biochain |
5 slides |
EUR 728 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
T1236171Dia |
Biochain |
5 slides |
EUR 523 |
Total Protein - Human Diabetic Diseased Tissue: Whole Eye |
P1236108Dia |
Biochain |
1 mg |
EUR 1319 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
T2236171Dia |
Biochain |
5 slides |
EUR 262 |
Total Protein - Human Diabetic Diseased Tissue: Bone Marrow |
P1236024Dia |
Biochain |
1 mg |
EUR 1319 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
T1236003SubDia |
Biochain |
5 slides |
EUR 728 |
Total Protein - Human Diabetic Diseased Tissue: Skeletal Muscle |
P1236171Dia |
Biochain |
1 mg |
EUR 542 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
T1236227Dia |
Biochain |
5 slides |
EUR 523 |
Total Protein - Human Diabetic Diseased Tissue: Visceral Adipose |
P1236003VisDia |
Biochain |
1 mg |
EUR 1319 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
T2236227Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
T1236230Dia |
Biochain |
5 slides |
EUR 523 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
T2236230Dia |
Biochain |
5 slides |
EUR 262 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
T1236101Dia |
Biochain |
5 slides |
EUR 523 |
Total Protein - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
P1236003SubDia |
Biochain |
1 mg |
EUR 1319 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
T2236101Dia |
Biochain |
5 slides |
EUR 262 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
P1236227Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
P1236101Dia |
Biochain |
1 mg |
EUR 542 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
P1236230Dia |
Biochain |
1 mg |
EUR 542 |
Genomic DNA - Human Diabetic Diseased Tissue: Lung, from a single donor |
D1236152Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Brain, from a single donor |
D1236035Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Colon, from a single donor |
D1236090Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Heart, from a single donor |
D1236122Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Liver, from a single donor |
D1236149Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Kidney, from a single donor |
D1236142Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Spleen, from a single donor |
D1236246Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Adrenal, from a single donor |
D1236004Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Stomach, from a single donor |
D1236248Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Esophagus, from a single donor |
D1236106Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Pancreas, from a single donor |
D1236188Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Whole Eye, from a single donor |
D1236108Dia |
Biochain |
50 ug |
EUR 1325 |
Genomic DNA - Human Diabetic Diseased Tissue: Bone Marrow, from a single donor |
D1236024Dia |
Biochain |
50 ug |
EUR 1325 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Skin, BioGenomics |
MBS652503-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Skin, BioGenomics |
MBS652503-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Genomic DNA - Human Diabetic Diseased Tissue: Visceral Adipose, from a single donor |
D1236003VisDia |
Biochain |
50 ug |
EUR 1325 |
Genomic DNA - Human Diabetic Diseased Tissue: Skeletal Muscle, from a single donor |
D1236171Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor |
D1236003SubDia |
Biochain |
50 ug |
EUR 1325 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum, from a single donor |
D1236227Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum, from a single donor |
D1236230Dia |
Biochain |
50 ug |
EUR 562 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum, from a single donor |
D1236101Dia |
Biochain |
50 ug |
EUR 562 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Brain, BioGenomics |
MBS652445-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Brain, BioGenomics |
MBS652445-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Colon, BioGenomics |
MBS651959-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Colon, BioGenomics |
MBS651959-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Heart, BioGenomics |
MBS652027-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Heart, BioGenomics |
MBS652027-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Liver, BioGenomics |
MBS652096-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Liver, BioGenomics |
MBS652096-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Lung, BioGenomics |
MBS652170-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Lung, BioGenomics |
MBS652170-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Spleen, BioGenomics |
MBS652375-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Spleen, BioGenomics |
MBS652375-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Stomach, BioGenomics |
MBS652568-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Stomach, BioGenomics |
MBS652568-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Kidney, BioGenomics |
MBS652243-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Kidney, BioGenomics |
MBS652243-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Esophagus, BioGenomics |
MBS651920-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Esophagus, BioGenomics |
MBS651920-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Pancreas, BioGenomics |
MBS652098-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Pancreas, BioGenomics |
MBS652098-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Whole Eye, BioGenomics |
MBS651936-10Tests |
MyBiosource |
10Tests |
EUR 680 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Whole Eye, BioGenomics |
MBS651936-5x10Tests |
MyBiosource |
5x10Tests |
EUR 2835 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Lymph Node, BioGenomics |
MBS652267-10Tests |
MyBiosource |
10Tests |
EUR 680 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Lymph Node, BioGenomics |
MBS652267-5x10Tests |
MyBiosource |
5x10Tests |
EUR 2835 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Bone Marrow, BioGenomics |
MBS652454-10Tests |
MyBiosource |
10Tests |
EUR 700 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Bone Marrow, BioGenomics |
MBS652454-5x10Tests |
MyBiosource |
5x10Tests |
EUR 2935 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Skin, BioGenomics |
MBS652450-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Skin, BioGenomics |
MBS652450-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Skeletal Muscle, BioGenomics |
MBS652443-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Skeletal Muscle, BioGenomics |
MBS652443-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Visceral Adipose, BioGenomics |
MBS652260-10Tests |
MyBiosource |
10Tests |
EUR 700 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Visceral Adipose, BioGenomics |
MBS652260-5x10Tests |
MyBiosource |
5x10Tests |
EUR 2935 |
Tissue, Total Protein, Human Disease, Diabetes, Skin |
MBS657133-1mg |
MyBiosource |
1mg |
EUR 820 |
Tissue, Total Protein, Human Disease, Diabetes, Skin |
MBS657133-5x1mg |
MyBiosource |
5x1mg |
EUR 3470 |
Tissue, Section, Human Disease, Diabetes, Skin (Frozen) |
MBS640139-5Slides |
MyBiosource |
5Slides |
EUR 755 |
Tissue, Section, Human Disease, Diabetes, Skin (Frozen) |
MBS640139-5x5Slides |
MyBiosource |
5x5Slides |
EUR 3170 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Subcutaneous Adipose, BioGenomics |
MBS652060-10Tests |
MyBiosource |
10Tests |
EUR 700 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Subcutaneous Adipose, BioGenomics |
MBS652060-5x10Tests |
MyBiosource |
5x10Tests |
EUR 2935 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Ileum, BioGenomics |
MBS652440-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Ileum, BioGenomics |
MBS652440-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Jejunum, BioGenomics |
MBS651908-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Jejunum, BioGenomics |
MBS651908-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Duodenum, BioGenomics |
MBS652227-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Diabetes, Small Intestine, Duodenum, BioGenomics |
MBS652227-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue, Genomic DNA, Human Disease (Adult), Diabetes, Skin, BioGenomics |
MBS654376-005mg |
MyBiosource |
0.05mg |
EUR 715 |
Tissue, Genomic DNA, Human Disease (Adult), Diabetes, Skin, BioGenomics |
MBS654376-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3075 |
Lung Diabetic Disease Lysate |
XBL-10362 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Colon Diabetic Disease Lysate |
XBL-10333 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Ileum Diabetic Disease Lysate |
XBL-10379 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Jejunum Diabetic Disease Lysate |
XBL-10381 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Stomach Diabetic Disease Lysate |
XBL-10387 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human stomach tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human stomach tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the stomach tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The stomach tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Duodenum Diabetic Disease Lysate |
XBL-10336 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Esophagus Diabetic Disease Lysate |
XBL-10338 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Pancrease Diabetic Disease Lysate |
XBL-10371 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human pancrease tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancrease tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancrease tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancrease tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total RNA - Diabetic Disease: Colon |
R1236090Dia-50 |
Biochain |
50 ug |
EUR 460 |
Total RNA - Diabetic Disease: Stomach |
R1236248Dia-50 |
Biochain |
50 ug |
EUR 460 |
Total RNA - Diabetic Disease: Pancreas |
R1236188Dia-50 |
Biochain |
50 ug |
EUR 460 |
Total RNA - Diabetic Disease: Esophagus |
R1236106Dia-50 |
Biochain |
50 ug |
EUR 460 |
Skeletal Muscle Diabetic Disease Lysate |
XBL-10369 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: human skeletal muscle tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skeletal muscle tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the Skeletal Muscle tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The Skeletal Muscle tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Tissue cDNA, First Strand, Human Diseased, Lupus, Lung, BioGenomics |
MBS652388-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Lung, BioGenomics |
MBS652388-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Heart, BioGenomics |
MBS652376-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Heart, BioGenomics |
MBS652376-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Colon, BioGenomics |
MBS652005-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Colon, BioGenomics |
MBS652005-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Liver, BioGenomics |
MBS652155-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Liver, BioGenomics |
MBS652155-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Pancreas Membrane Diabetic Disease Lysate |
XBL-10785 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: Human pancreas tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human pancreas tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated pancreas tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated pancreas tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
Tissue cDNA, First Strand, Human Diseased, Lupus, Kidney, BioGenomics |
MBS651861-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Kidney, BioGenomics |
MBS651861-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Spleen, BioGenomics |
MBS651949-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Spleen, BioGenomics |
MBS651949-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Membrane Protein - Diabetic Disease: Pancreas |
P3236188Dia |
Biochain |
0.1 mg |
EUR 472 |
Tissue cDNA, First Strand, Human Diseased, Lupus, stomach, BioGenomics |
MBS652163-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, stomach, BioGenomics |
MBS652163-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Alzheimer's Disease, Brain, BioGenomics |
MBS652514-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Alzheimer's Disease, Brain, BioGenomics |
MBS652514-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Diaphragm, BioGenomics |
MBS651903-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Diaphragm, BioGenomics |
MBS651903-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Pancreas, BioGenomics |
MBS652511-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Pancreas, BioGenomics |
MBS652511-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Adipose Subcutaneous Diabetic Disease Lysate |
20-105 |
ProSci |
0.1 mg |
EUR 1508.1 |
Description: Human subcutaneous adipose tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human subcutaneous adipose tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the subcutaneous adipose tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The subcutaneous adipose tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Tissue cDNA, First Strand, Human Diseased, Lupus, Spinal cord, BioGenomics |
MBS652411-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Lupus, Spinal cord, BioGenomics |
MBS652411-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Skeletal Muscle Membrane Diabetic Disease Lysate |
XBL-10855 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: human skeletal muscle tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human skeletal muscle tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Skeletal Muscle tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Skeletal Muscle tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
Tissue cDNA, First Strand, Human Diseased (Adult), Parkinson's Disease, Brain, BioGenomics |
MBS652455-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased (Adult), Parkinson's Disease, Brain, BioGenomics |
MBS652455-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Alzheimer's Disease, Brain, Pons, BioGenomics |
MBS652281-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Alzheimer's Disease, Brain, Pons, BioGenomics |
MBS652281-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Membrane Protein - Diabetic Disease: Skeletal Muscle |
P3236171Dia |
Biochain |
0.1 mg |
EUR 472 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lung, BioGenomics |
MBS651928-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lung, BioGenomics |
MBS651928-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Colon, BioGenomics |
MBS652319-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Colon, BioGenomics |
MBS652319-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
We additionally measured the 3D distribution of fluorescently labeled Ag nanoparticles in cleared pores and skin biopsies with wounded epidermal layers utilizing gentle sheet fluorescence microscopy. Total, this research explores a novel technique for quantitatively mapping ENM distributions in cleared ex vivo human pores and skin tissue fashions utilizing a number of imaging modalities. By bettering the imaging distinction, we current label-free 2D ENM monitoring and 3D ENM mapping as promising capabilities for nanotoxicology investigations.